title: A favourable effect of recombinant human erythropoietin in three cases of leukaemic transformation from chronic myelomonocytic leukaemia.
authors.affiliation: Clinica Medica Università, di Milano Ospedale S. Paolo, Italia.
authors.forename: L
authors.initials: L
authors.lastname: Uziel
authors.forename: I
authors.initials: I
authors.lastname: Fabrizi
authors.forename: M L
authors.initials: ML
authors.lastname: Zighetti
authors.forename: G
authors.initials: G
authors.lastname: Carpani
authors.forename: A
authors.initials: A
authors.lastname: Rosti
authors.forename: G A
authors.initials: GA
authors.lastname: Moroni
authors.forename: A
authors.initials: A
authors.lastname: Marmont
mesh_terms: D000368:Aged; D001752:Blast Crisis / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000097:blood / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D012156:Reticulocytes / Q000473:pathology
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin